Search Results - "Molloy, Eamonn S"

Refine Results
  1. 1

    PML and rheumatology: the contribution of disease and drugs by Molloy, Eamonn S

    Published in Cleveland Clinic journal of medicine (01-11-2011)
    “…Progressive multifocal leukoencephalopathy (PML), a rare, typically fatal, opportunistic infection caused by the JC virus, is becoming relevant to physicians…”
    Get full text
    Journal Article
  2. 2

    Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: Evolving role of biologic therapies by Molloy, Eamonn S., Calabrese, Leonard H.

    Published in Arthritis & rheumatology (Hoboken, N.J.) (01-09-2012)
    “…Objective To evaluate the association of progressive multifocal leukoencephalopathy (PML) with immunosuppressive therapy for autoimmune rheumatic diseases…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Proneoplastic effects of PGE2 mediated by EP4 receptor in colorectal cancer by Doherty, Glen A, Byrne, Sinead M, Molloy, Eamonn S, Malhotra, Vikrum, Austin, Sandra C, Kay, Elaine W, Murray, Frank E, Fitzgerald, Desmond J

    Published in BMC cancer (26-06-2009)
    “…Prostaglandin E2 (PGE2) is the major product of Cyclooxygenase-2 (COX-2) in colorectal cancer (CRC). We aimed to assess PGE2 cell surface receptors (EP 1-4) to…”
    Get full text
    Journal Article
  6. 6

    The role of toll like receptors in giant cell arteritis by O'Neill, Lorraine, Molloy, Eamonn S

    Published in Rheumatology (Oxford, England) (01-11-2016)
    “…GCA is a common primary systemic vasculitis that results in granulomatous inflammation of medium to large arteries. Both innate and adaptive immune mechanisms…”
    Get full text
    Journal Article
  7. 7

    Ustekinumab for refractory giant cell arteritis: A prospective 52-week trial by Conway, Richard, O'Neill, Lorraine, Gallagher, Phil, McCarthy, Geraldine M., Murphy, Conor C., Veale, Douglas J., Fearon, Ursula, Molloy, Eamonn S.

    Published in Seminars in arthritis and rheumatism (01-12-2018)
    “…Giant cell arteritis (GCA) is the most common form of systemic vasculitis. Glucocorticoids are an effective treatment but have significant adverse events and…”
    Get full text
    Journal Article
  8. 8

    Successful reconstruction of an ocular defect resulting from granulomatosis with polyangiitis, following treatment with rituximab by Kenny, Grace M, Holl-Ulrich, Konstanze, Fulcher, Timothy, McElnea, Elizabeth, Kavanagh, Eoin, Moriarty, Heather, Mulligan, Niall, Molloy, Eamonn S, McCarthy, Geraldine M

    “…To report a unique case of orbital inflammatory disease which was ultimately diagnosed as granulomatosis with polyangitis (GPA) and thus successfully treated…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Interleukin 12 and interleukin 23 play key pathogenic roles in inflammatory and proliferative pathways in giant cell arteritis by Conway, Richard, O'Neill, Lorraine, McCarthy, Geraldine M, Murphy, Conor C, Fabre, Aurelie, Kennedy, Susan, Veale, Douglas J, Wade, Sarah M, Fearon, Ursula, Molloy, Eamonn S

    Published in Annals of the rheumatic diseases (01-12-2018)
    “…The pathogenesis of giant cell arteritis (GCA) remains unclear. T 1 and T 17 pathways are implicated, but the proximal initiators and effector cytokines are…”
    Get more information
    Journal Article
  12. 12

    The Risk of Progressive Multifocal Leukoencephalopathy in the Biologic Era: Prevention and Management by Molloy, Eamonn S, Calabrese, Cassandra M, Calabrese, Leonard H

    “…Progressive multifocal leukoencephalopathy (PML) is a rare, typically fatal, demyelinating central nervous system infection caused by reactivation of the John…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: Are patients with systemic lupus erythematosus at particular risk? by Molloy, Eamonn S, Calabrese, Leonard H

    Published in Autoimmunity reviews (01-12-2008)
    “…Abstract Progressive multifocal leukoencephalopathy (PML) is a rare, frequently fatal, infectious complication occurring in immunocompromised patients. PML has…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Progressive multifocal leukoencephalopathy: A national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases by Molloy, Eamonn S., Calabrese, Leonard H.

    Published in Arthritis and rheumatism (01-12-2009)
    “…Objective Progressive multifocal leukoencephalopathy (PML) is a rare, typically fatal, central nervous system demyelinating disease that results from…”
    Get full text
    Journal Article
  17. 17

    Basic calcium phosphate crystals: pathways to joint degeneration by Molloy, Eamonn S, McCarthy, Geraldine M

    Published in Current opinion in rheumatology (01-03-2006)
    “…PURPOSE OF REVIEWBasic calcium phosphate crystals have long been associated with rheumatic syndromes. Although an understanding of the molecular mechanisms…”
    Get full text
    Journal Article
  18. 18

    Diagnostic Utility of Computed Tomographic Angiography in Giant-Cell Arteritis by Conway, Richard, Smyth, Anna E, Kavanagh, Richard G, O’Donohoe, Rory L, Purcell, Yvonne, Heffernan, Eric J, Molloy, Eamonn S, McNeill, Graeme, Killeen, Ronan P

    Published in Stroke (1970) (01-09-2018)
    “…BACKGROUND AND PURPOSE—The diagnosis of giant-cell arteritis (GCA) is challenging. Superficial temporal artery biopsy and ultrasound are positive in only 50%…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Targeted but not trouble-free: efalizumab and PML by Molloy, Eamonn S., Calabrese, Leonard H.

    Published in Nature reviews. Rheumatology (01-08-2009)
    “…In April 2009, efalizumab was withdrawn from the market for the treatment of psoriasis after reports emerged of an association between long-term therapy and…”
    Get full text
    Journal Article